Tobacco Mosaic Virus Delivery of Phenanthriplatin for Cancer therapy

ACS Nano

Volumn 10, Issue 4, 2016, Pages 4119-4126

  Czapar, Anna E ^a   Zheng, Yao Rong ^e   Riddell, Imogen A ^e   Shukla, Sourabh ^b   Awuah, Samuel G ^e   Lippard, Stephen J ^e   Steinmetz, Nicole F ^a,b,c,d  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Case Western Reserve University   (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

^d Case Western Reserve University   (United States)

^e MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

cancer therapy; drug delivery; metals in medicine; nanotechnology; tobacco mosaic virus

Indexed keywords

DRUG DELIVERY; NANOTECHNOLOGY; ONCOLOGY; PLATINUM; PLATINUM COMPOUNDS; TOBACCO; TUMORS; VIRUSES; YARN;

ACIDIC ENVIRONMENT; CANCER THERAPY; CELLULAR RESPONSE; INTERIOR SURFACES; LOADING PROTOCOLS; NATIVE STRUCTURES; TOBACCO MOSAIC VIRUS; TRIPLE-NEGATIVE BREAST CANCERS;

DISEASES;

ANTINEOPLASTIC AGENT; CISPLATIN; PHENANTHRIDINE DERIVATIVE; PHENANTHRIPLATIN; PLATINUM COMPLEX;

ANIMAL; BAGG ALBINO MOUSE; CELL SURVIVAL; DRUG DELIVERY SYSTEM; GENETICS; HUMAN; NUDE MOUSE; TISSUE DISTRIBUTION; TOBACCO MOSAIC VIRUS; TRIPLE NEGATIVE BREAST CANCER; TUMOR CELL LINE; XENOGRAFT;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL SURVIVAL; CISPLATIN; DRUG DELIVERY SYSTEMS; HETEROGRAFTS; HUMANS; MICE, INBRED BALB C; MICE, NUDE; ORGANOPLATINUM COMPOUNDS; PHENANTHRIDINES; TISSUE DISTRIBUTION; TOBACCO MOSAIC VIRUS; TRIPLE NEGATIVE BREAST NEOPLASMS;

EID: 84968760260     PISSN: 19360851     EISSN: 1936086X     Source Type: Journal    
DOI: 10.1021/acsnano.5b07360     Document Type: Article

References (32)

1. Yao, X.; Panichpisal, K.; Kurtzman, N.; Nugent, K. Cisplatin Nephrotoxicity: A Review Am. J. Med. Sci. 2007, 334, 115-124 10.1097/MAJ.0b013e31812dfe1e
2. Cooke, S. L.; Brenton, J. D. Evolution of Platinum Resistance in High-Grade Serous Ovarian Cancer Lancet Oncol. 2011, 12, 1169-1174 10.1016/S1470-2045(11)70123-1
3. White, S. C.; Lorigan, P.; Margison, G. P.; Margison, J. M.; Martin, F.; Thatcher, N.; Anderson, H.; Ranson, M. Phase II Study of SPI-77 (Sterically Stabilised Liposomal Cisplatin) in Advanced Non-Small-Cell Lung Cancer Br. J. Cancer 2006, 95, 822-828 10.1038/sj.bjc.6603345
4. Park, G. Y.; Wilson, J. J.; Song, Y.; Lippard, S. J. Phenanthriplatin, a Monofunctional DNA-Binding Platinum Anticancer Drug Candidate with Unusual Potency and Cellular Activity Profile Proc. Natl. Acad. Sci. U. S. A. 2012, 109, 11987-11992 10.1073/pnas.1207670109
5. Kellinger, M. W.; Park, G. Y.; Chong, J.; Lippard, S. J.; Wang, D. Effect of a Monofunctional Phenanthriplatin-DNA Adduct on RNA Polymerase II Transcriptional Fidelity and Translesion Synthesis J. Am. Chem. Soc. 2013, 135, 13054-13061 10.1021/ja405475y
6. Gregory, M. T.; Park, G. Y.; Johnstone, T. C.; Lee, Y. S.; Yang, W.; Lippard, S. J. Structural and Mechanistic Studies of Polymerase η Bypass of Phenanthriplatin DNA Damage Proc. Natl. Acad. Sci. U. S. A. 2014, 111, 9133-9138 10.1073/pnas.1405739111
7. Johnstone, T. C.; Park, G. Y.; Lippard, S. J. Understanding and Improving Platinum Anticancer Drugs - Phenanthriplatin Anticancer Res. 2014, 34, 471-476
8. Liu, T. C.; Galanis, E.; Kirn, D. Clinical Trial Results with Oncolytic Virotherapy: A Century of Promise, a Decade of Progress Nat. Clin. Pract. Oncol. 2007, 4, 101-117 10.1038/ncponc0736
9. Giacca, M.; Zacchigna, S. Virus-Mediated Gene Delivery for Human Gene Therapy J. Controlled Release 2012, 161, 377-388 10.1016/j.jconrel.2012.04.008
10. Bruckman, M. A.; Randolph, L. N.; Vanmeter, A.; Hern, S.; Shoffstall, A. J.; Taurog, R. E.; Steinmetz, N. F. Biodistribution, Pharmacokinetics, and Blood Compatibility of Native and Pegylated Tobacco Mosaic Virus Nano-Rods and -Spheres in Mice Virology 2014, 449, 163-173 10.1016/j.virol.2013.10.035
11. Shukla, S.; Eber, F. J.; Nagarajan, A. S.; DiFranco, N. A.; Schmidt, N.; Wen, A. M.; Eiben, S.; Twyman, R. M.; Wege, C.; Steinmetz, N. F. The Impact of Aspect Ratio on the Biodistribution and Tumor Homing of Rigid Soft-Matter Nanorods Adv. Healthcare Mater. 2015, 4, 874-882 10.1002/adhm.201400641
12. Geng, Y.; Dalhaimer, P.; Cai, S.; Tsai, R.; Tewari, M.; Minko, T.; Discher, D. E. Shape Effects of Filaments Versus Spherical Particles in Flow and Drug Delivery Nat. Nanotechnol. 2007, 2, 249-255 10.1038/nnano.2007.70
13. Chauhan, V. P.; Popović, Z.; Chen, O.; Cui, J.; Fukumura, D.; Bawendi, M. G.; Jain, R. K. Fluorescent Nanorods and Nanospheres for Real-Time in Vivo Probing of Nanoparticle Shape-Dependent Tumor Penetration Angew. Chem., Int. Ed. 2011, 50, 11417-11420 10.1002/anie.201104449
14. Bruckman, M.; Jiang, K.; Simpson, E. J.; Randolph, L.; Luyt, L. G.; Yu, X.; Steinmetz, N. F. Dual-Modal Magnetic Resonance and Fluorescence Imaging of Atherosclerotic Plaques in Vivo Using VCAM-1 Targeted Tobacco Mosaic Virus Nano Lett. 2014, 14, 1551-1558 10.1021/nl404816m
15. Bruckman, M. A.; Steinmetz, N. F. Chemical Modification of the Inner and Outer Surfaces of Tobacco Mosaic Virus (TMV) Methods Mol. Biol. 2014, 1108, 173-185 10.1007/978-1-62703-751-8_13
16. Klug, A. The Tobacco Mosaic Virus Particle: Structure and Assembly Philos. Trans. R. Soc., B 1999, 354, 531-535 10.1098/rstb.1999.0404
17. Bruckman, M. A.; Hern, S.; Jiang, K.; Flask, C. A.; Yu, X.; Steinmetz, N. F. Tobacco Mosaic Virus Rods and Spheres as Supramolecular High-Relaxivity MRI Contrast Agents J. Mater. Chem. B 2013, 1, 1482-1490 10.1039/c3tb00461a
18. Brunel, F. M.; Lewis, J. D.; Destito, G.; Steinmetz, N. F.; Manchester, M.; Stuhlmann, H.; Dawson, P. E. Hydrazone Ligation Strategy to Assemble Multifunctional Viral Nanoparticles for Cell Imaging and Tumor Targeting Nano Lett. 2010, 10, 1093-1097 10.1021/nl1002526
19. Wu, Z.; Chen, K.; Yildiz, I.; Dirksen, A.; Fischer, R.; Dawson, P. E.; Steinmetz, N. F. Development of Viral Nanoparticles for Efficient Intracellular Delivery Nanoscale 2012, 4, 3567-3576 10.1039/c2nr30366c
20. Du, J.; Lane, L. A.; Nie, S. Stimuli-Responsive Nanoparticles for Targeting the Tumor Microenvironment J. Controlled Release 2015, 219, 205-214 10.1016/j.jconrel.2015.08.050
21. Behrens, B. C.; Hamilton, T. C.; Masuda, H.; Grotzinger, K. R.; Whang-Peng, J.; Louie, K. G.; Knutsen, T.; McKoy, W. M.; Young, R. C.; Ozols, R. F. Characterization of a Cis-Diamminedichloroplatinum-(II)-Resistant Human Ovarian Cancer Cell Line and Its Use in Evaluation of Platinum Analogues Cancer Res. 1987, 47, 414-418
22. Nagaraj, A. B.; Joseph, P.; Kovalenko, O.; Singh, S.; Armstrong, A.; Redline, R.; Resnick, K.; Zanotti, K.; Waggoner, S.; DiFeo, A. Critical Role of Wnt/β-Catenin Signaling in Driving Epithelial Ovarian Cancer Platinum Resistance Oncotarget 2015, 6, 23720-23734 10.18632/oncotarget.4690
23. Aljabali, A. A.; Shukla, S.; Lomonossoff, G. P.; Steinmetz, N. F.; Evans, D. J. CPMV-Dox Delivers Mol. Pharmaceutics 2013, 10, 3-10 10.1021/mp3002057
24. Wen, A. M.; Infusino, M.; De Luca, A.; Kernan, D. L.; Czapar, A. E.; Strangi, G.; Steinmetz, N. F. Interface of Physics and Biology: Engineering Virus-Based Nanoparticles for Biophotonics Bioconjugate Chem. 2015, 26, 51-62 10.1021/bc500524f
25. Maeda, H.; Wu, J.; Sawa, T.; Matsumura, Y.; Hori, K. Tumor Vascular Permeability and the EPR Effect in Macromolecular Therapeutics: A Review J. Controlled Release 2000, 65, 271-284 10.1016/S0168-3659(99)00248-5
26. Lee, K. L.; Shukla, S.; Wu, M.; Ayat, N. R.; El Sanadi, C. E.; Wen, A. M.; Edelbrock, J. F.; Pokorski, J. K.; Commandeur, U.; Dubyak, G. R.; Steinmetz, N. F. Stealth Filaments: Polymer Chain Length and Conformation Affect the in Vivo Fate of Pegylated Potato Virus X Acta Biomater. 2015, 19, 166-179 10.1016/j.actbio.2015.03.001
27. LeBond, R. F.; D. D, B.; Suneja, M.; Szot, J. F.; DeGowin, E. L., Common Laboratory Tests. In DeGowin's Diagnostic Examination, 10 th ed.; McGraw-Hill Education/Medical: New York, 2015.
28. Miller, M. A.; Zheng, Y. R.; Gadde, S.; Pfirschke, C.; Harshal, Z.; Engblom, C.; Kohler, R. H.; Iwamoto, Y.; Yang, K. S.; Askevold, B.; Kolishetti, N.; Pittet, M.; Lippard, S. J.; Farokhzad, O. C.; Weissleder, R. Tumour-associated macrophages act as a slow-release reservoir of nano-therapeutic Pt(IV) pro-drug Nat. Commun. 2015, 6, 8692 10.1038/ncomms9692
29. Lizotte, P. H.; Wen, A. M.; Sheen, M. R.; Fields, J.; Rojanasopondist, P.; Steinmetz, N. F.; Fiering, S. In Situ Vaccination with Cowpea Mosaic Virus Nanoparticles Suppresses Metastatic Cancer Nat. Nanotechnol. 2015, 11, 295-303 10.1038/nnano.2015.292
30. Kaiser, C. R.; Flenniken, M. L.; Gillitzer, E.; Harmsen, A. L.; Harmsen, A. G.; Jutila, M. A.; Douglas, T.; Young, M. J. Biodistribution Studies of Protein Cage Nanoparticles Demonstrate Broad Tissue Distribution and Rapid Clearance in Vivo Int. J. Nanomed. 2007, 2, 715-733
31. Yildiz, I.; Shukla, S.; Steinmetz, N. F. Applications of Viral Nanoparticles in Medicine Curr. Opin. Biotechnol. 2011, 22, 901-908 10.1016/j.copbio.2011.04.020
32. Fischer, A. H.; Jacobson, K. A.; Rose, J.; Zeller, R. Hematoxylin and Eosin Staining of Tissue and Cell Sections Cold Spring Harbor Protoc. 2008, 2008, pdb.prot4986 10.1101/pdb.prot4986